Not all supplement companies are created equal. The difference between a quality manufacturer and a corner-cutting operation can mean the difference between a product that works and one that contains contaminants, underdosed ingredients, or outright mislabeled compounds. Here is how to evaluate supplement companies using a harm reduction framework.
Third-Party Testing Is the Minimum Standard
Any reputable supplement company should have their products tested by an independent third-party lab. This means an organization with no financial relationship to the company verifies that what is on the label matches what is in the bottle. Look for certifications from NSF International, Informed Sport, USP, or individual COAs (Certificates of Analysis) that are publicly available.
If a company cannot or will not provide third-party testing results, that is an immediate red flag. The cost of testing is minimal relative to production costs — companies that skip it are either cutting corners or hiding something.
Avoid Proprietary Blends
A proprietary blend lists ingredients but hides the individual doses behind a total “blend” weight. This means a product could contain 99% of the cheapest ingredient and trace amounts of the expensive, effective ones — and you would never know. Companies that use proprietary blends are prioritizing marketing over transparency.
Look for products with fully disclosed labels showing exact milligram amounts of every ingredient. Then cross-reference those amounts against the clinical research to verify they match doses that were actually shown to be effective in studies.
Check the Dose Against Research
A product can contain all the right ingredients at all the wrong doses. If a study showed that 500mg of an ingredient produced results, and the supplement contains 50mg, you are paying for a label claim — not an effective dose. This is called “fairy dusting” in the industry, and it is rampant. This principle of dose-response accuracy is a direct application of the Tony Huge Laws of Biochemistry Physics; an insufficient dose cannot produce the intended biochemical effect, regardless of the ingredient’s theoretical potential.
Manufacturing Standards
cGMP (current Good Manufacturing Practices) certification means the facility follows FDA-established guidelines for supplement production. This covers sanitation, equipment maintenance, quality control, and record-keeping. It does not guarantee the product works — but it guarantees a baseline level of manufacturing quality and safety.
The bottom line: treat supplement purchasing the same way you would treat any other health decision. Research the company, verify the claims, check the doses, and demand transparency. Your health depends on what is actually in the bottle, not what is on the marketing page.
Interesting Perspectives
While the core principles of third-party testing and transparency are non-negotiable, the landscape of supplement sourcing is evolving. Savvy biohackers are looking beyond the label to the source material itself. There’s a growing interest in “single-origin” or “traceable” raw materials, where the specific farm, harvest batch, or even plant cultivar is documented. This is particularly relevant for botanicals like ashwagandha or turmeric, where phytochemical profiles can vary wildly. Some argue that the future of quality assurance lies in blockchain-like ledgers for ingredient provenance, moving from verifying purity to verifying potency and origin. Another emerging angle is the scrutiny of “inactive” ingredients. Fillers, binders, and flow agents like magnesium stearate are generally recognized as safe, but high-performance users question their potential impact on absorption rates and gut health, seeking out capsules with minimal excipients. Finally, the rise of direct-to-consumer brands that own their manufacturing (vertical integration) is seen as a positive shift, as it reduces the number of hands in the supply chain where contamination or substitution can occur.
Citations & References
- Cohen, P. A., Maller, G., DeSouza, R., & Neal-Kababick, J. (2014). Presence of banned drugs in dietary supplements following FDA recalls. JAMA, 312(16), 1691–1693. (This study highlights the critical need for post-market surveillance and third-party testing, as banned substances were found in supplements even after FDA recalls).
- Gurley, B. J., Steelman, S. C., & Thomas, S. L. (2015). Multi-ingredient, caffeine-containing dietary supplements: history, safety, and efficacy. Clinical Therapeutics, 37(2), 275–301. (Discusses the challenges of safety and efficacy assessment in complex blends, underscoring the risks of proprietary formulations).
- U.S. Food and Drug Administration. (2022). Current Good Manufacturing Practice (CGMP) Regulations. FDA.gov. (The official regulatory framework that defines the minimum quality standards for dietary supplement manufacturing).
- Avigan, M. I., Mozersky, R. P., & Seeff, L. B. (2016). Scientific and regulatory perspectives in herbal and dietary supplement associated hepatotoxicity in the United States. International Journal of Molecular Sciences, 17(3), 331. (Reviews the hepatotoxic risks associated with adulterated or mislabeled supplements, emphasizing the role of quality control).
- Maughan, R. J., Burke, L. M., Dvorak, J., et al. (2018). IOC consensus statement: dietary supplements and the high-performance athlete. British Journal of Sports Medicine, 52(7), 439–455. (The International Olympic Committee advises athletes to use only supplements that have undergone independent testing to minimize risk of inadvertent doping).